drugset / Trial / NCT07140640
Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.
NaFactorialOpen-labelPrevention
Summary
Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.
Timeline
- Start
- 2025-09-15
- Primary completion
- 2026-03-15
- Completion
- 2026-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 10 mg | Intrathecal |
| Comparator | Bupivacaine | Other / unclassified | 12.5 mg | Intrathecal |
| Comparator | Fentanyl | Other / unclassified | 25 ug | Intrathecal |
Indications
No indication recorded.